Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 01, 2026, titled "Zydus receives EIR from the USFDA for its injectable facility with VAI classification".
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 01, 2026, titled "Zydus receives EIR from the USFDA for its injectable facility with VAI classification".